Clinical Trials Logo

Clinical Trial Summary

The investigators hypotheses that paclitaxel combined with cisplatin in a weekly-based regimen as adjuvant chemotherapy is more effective for high risk, HER2 negative breast cancer .

Clinical Trial Description

In this trial, patients will be randomly assigned in a 2:1 ratio to receive cisplatin-based adjuvant chemotherapy and to standard adjuvant chemotherapy. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03201861
Study type Interventional
Source RenJi Hospital
Contact Yueyao Du, M.D.
Phone 86-21-68385569
Status Recruiting
Phase Phase 3
Start date April 10, 2018
Completion date December 31, 2021